Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elles Zock

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|July 4, 2012
[Initial reactions of patients after a stroke: more than half undertake no action]Elles Zock, Henk Kerkhoff, Ruud P Kleyweg
Acta Neurologica Belgica|January 7, 2016
Intrinsic factors influencing help-seeking behaviour in an acute stroke situationElles Zock, Henk Kerkhoff, Ruud Peter Kleyweg, et al.
Cerebrovascular Diseases (Basel, Switzerland)|March 22, 2023
The Frequency of CYP2C19 Loss-of-Function Variants in Patients with Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack in the Dutch PopulationLotte van den Heuvel, Henricus J Vermeer, Henk Kerkhoff, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 30, 2026
[Two patients with CC9 intoxication: unexpected symptoms of a novel synthetic cannabinoid]Denne A Scharink, Hugo C Hoogeveen, Daan Vlot, et al.
Cerebrovascular Diseases (Basel, Switzerland)|May 14, 2014
The effect of a slower than standard dose escalation scheme for dipyridamole on headaches in secondary prevention therapy of strokes: a randomized, open-label trial (DOSE)N C Martine de Vos-Koppelaar, Henk Kerkhoff, Ed M de Vogel, et al.
Neurology|April 8, 2018
Preventive Antibiotics in Stroke Study (PASS): A cost-effectiveness studyWilleke F Westendorp, Elles Zock, Jan-Dirk Vermeij, et al.
Lancet (London, England)|January 24, 2015
The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trialWilleke F Westendorp, Jan-Dirk Vermeij, Elles Zock, et al.
The Lancet. Neurology|October 23, 2021
Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trialFloris H B M Schreuder, Koen M van Nieuwenhuizen, Jeannette Hofmeijer, et al.
The Lancet. Neurology|May 19, 2024
Safety and efficacy of active blood-pressure reduction to the recommended thresholds for intravenous thrombolysis in patients with acute ischaemic stroke in the Netherlands (TRUTH): a prospective, observational, cluster-based, parallel-group studyThomas P Zonneveld, Sarah E Vermeer, Erik W van Zwet, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|July 4, 2012
[Initial reactions of patients after a stroke: more than half undertake no action]Elles Zock, Henk Kerkhoff, Ruud P Kleyweg
Acta Neurologica Belgica|January 7, 2016
Intrinsic factors influencing help-seeking behaviour in an acute stroke situationElles Zock, Henk Kerkhoff, Ruud Peter Kleyweg, et al.
Cerebrovascular Diseases (Basel, Switzerland)|March 22, 2023
The Frequency of CYP2C19 Loss-of-Function Variants in Patients with Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack in the Dutch PopulationLotte van den Heuvel, Henricus J Vermeer, Henk Kerkhoff, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 30, 2026
[Two patients with CC9 intoxication: unexpected symptoms of a novel synthetic cannabinoid]Denne A Scharink, Hugo C Hoogeveen, Daan Vlot, et al.
Cerebrovascular Diseases (Basel, Switzerland)|May 14, 2014
The effect of a slower than standard dose escalation scheme for dipyridamole on headaches in secondary prevention therapy of strokes: a randomized, open-label trial (DOSE)N C Martine de Vos-Koppelaar, Henk Kerkhoff, Ed M de Vogel, et al.
Neurology|April 8, 2018
Preventive Antibiotics in Stroke Study (PASS): A cost-effectiveness studyWilleke F Westendorp, Elles Zock, Jan-Dirk Vermeij, et al.
Lancet (London, England)|January 24, 2015
The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trialWilleke F Westendorp, Jan-Dirk Vermeij, Elles Zock, et al.
The Lancet. Neurology|October 23, 2021
Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trialFloris H B M Schreuder, Koen M van Nieuwenhuizen, Jeannette Hofmeijer, et al.
The Lancet. Neurology|May 19, 2024
Safety and efficacy of active blood-pressure reduction to the recommended thresholds for intravenous thrombolysis in patients with acute ischaemic stroke in the Netherlands (TRUTH): a prospective, observational, cluster-based, parallel-group studyThomas P Zonneveld, Sarah E Vermeer, Erik W van Zwet, et al.
Pageof 1